FDA Investigator Don H Bark, PhD

Don H Bark, PhD has inspections in 11 countries as of 20 Jul 2023. Don H Bark, PhD has collaborated with a combinined 3963 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
27
Last Inspection Date:
20 Jul 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Italy, Spain, United States of America, Germany, Netherlands, Switzerland, Finland, Ireland, United Kingdom of Great Britain and Northern Ireland, Canada, Denmark
Co-Investigator(s):
Ademola O Daramola, Alan P Kurtzberg, Alexander M Kay, Alice S Tsao, Anastasia M Shields, Angela E Glenn, Anita Narula, PhD, Anjali Shukla, PhD, Anthony F Lorenzo, Arlene M Badillo, Ashar P Parikh, Astrida B Mattson, Barbara Janine Breithaupt, Bijoy Panicker, Bo Chi, PhD, Bradley Dworak, PhD, Brian D Nicholson, Bruce H Mccullough, Bryan L Mcguckin, Carla J Lundi, Caryn M Mcnab, Charisse K Green, Charles I Ann, Charles M Edwards, Charles R Cote, RIC, Christian D Lynch (CDL), Christina A Miller, Christine A Harman, PhD, Christopher D Leach, Christopher R Czajka, Christopher T Middendorf, Connie P Rezendes, Connie P Rezenes, Cynthia A Palmer, Cynthia J Lee, MS, Cynthia Jim, CSO, Cynthia M Goudeau, Dandan Wang, PhD, David J Hafner, David M Beltran, David Perkins, Dawn E Barkans, Demitria J Xiradakis, Dennis Cantellops Paite, Denti Back, Dolores E Price, Don Bark, PhD, Donald C Obenhuber, PhD, Donald H Barks, Douglas A Campbell, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Carmelo Rosa, Edmund F Mrak, Jr, Edward D Mcdonald, Edwin Melendez, Eileen A Liu, Farhana Khan, Felix Maldonado, Francis A Guidry, Gayle S Lawson, George J Flynn, Geraldine D Sanders, Gerard Pde Leon, Gloria J Baca, MS, Gwyn G Dickinson, Heika R Bounds, Heika R Tait, Helen B Ricalde, Jacqueline Mdiaz Albertini, James I Giefer, James L Dunnie, Jr, James P Mcevoy, James S Stuart, BS, Jeffrey A Sommers, Jeffrey D Meng, Jen Sui, Jennifer L Bridgewater, Jennifer L Schmidt, Jennifer M Gogley, Jessica L Pressley, Joey V Quitania, John A Podsadowski, John P Mistler, Jose A Cruz, Jose Acruz Gonzalez, Joshua P Wireman, Kalavati Suvarna, PhD, Kari M Johansen, Kathryn A Krentz, Kathryn E Ogger, Kenneth O Gee, PhD, Kent C Faul, Kevin D Kallander, Kham Phommachanh, Kim Lthomas Cruse, Kip J Hanks, Kristin M Abaonza, Kristopher J Stanya, PhD, Larry K Austin, Lata C Mathew, PhD, Laura Fontan, MS, Laurel A Beer, Lawrence Y Lee, PhD, LCDR Chad N Thompson, LCDR Debra Emerson, Linan Ha, PhD, Linda M Cheny, Lisa K Capron, Lisa M Bellows, Luis A Dasta, Lydia Irosas Marty, Lynda L Perry, PhD, Maida Henesian (NMI), Marcus A Ray, Margaret M Annes, Maria Pkelly Doggett, MBA, Marie A Fadden, Marie M Fadden, Marijo B Kambere, PhD, Mariza M Jafary, Marjorie A Shapiro, PhD, Mark W Babbitt, Marlene G Swider, Matthew B Casale, Maxine H Wong, Megan A Haggerty, Mei Chiung J Huang, Meisha R Sampson, Meisha Waters, Meyer J Slobotsky, Michael E Maselli, Michael P Sheehan, Michael R Klapal, Michael Shanks, MS, Michele L Forster, PhD, Michele L Obert, Michelle Y Clark Stuart, Miguel A Martinez, Mihaly S Ligmond, Mikel T Wright, Mra Davism, Mra Mcculloughj, Mra Munizn, Nadeem I Chaudhry, Nancy A Saxenian Emmons, Nancy G Schmidt, Nebil A Oumer, Nicole A Lloyd, Omotunde O Osunsanmi, Pal S Mayasandra, Parul M Patel, Patrick C Klotzbuecher, Patsy J Domingo, Paul A Bonneau, Paul L Bellamy, Paula A Trost, Peter C Chow, Philip F Istafanos, DMV, MS, Prabhu P Raju, Rachel C Harrington, Randy L Self, Rebecca Rodriguez, Regina T Brown, Richard E Needham, Richard L Rutherford, Robert C Coleman, Robert C Steyert, Robert D Tollefsen, Rose M Ashley, Roy R Rinc, Russell J Glapion, S Lori Brown, PhD MPH, Saleem A Akhtar, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Santos E Camara, Sarah A Hassas, Scott T Ballard, Seneca D Toms, Sharon K Thoma, PharmD, Shawn R Gould, Shuen G Chai, Sidney B Priesmeyer, Sixto M Mercado, Sixto M Mercado Rios, Stephen D Eich, Steven A Gonzales, Steven C Madzo, Steven M Weinman, Sunitha K Rajaram, PhD, Susan D Yuscius, Susan F Laska, MS, Susan M Jackson, Susanna E Ford, Analyst, Terri L Dodds, Terry L Dodds, Thomas A Peter, Thomas J Arista, Tina S Roecklein, Tonia F Bernard, Tracey L Harris, Tracy K Li, Travis S Bradley, Unnee Ranjan, Uttaniti Limchumroon (Tom), Veronica Fuentes, MS, Virgilio F Pacio, CSO, Vlada Matusovsky, Wayne E Seifert, Xiaokuang Lai, PhD, Xiomara Copeland, Yasamin Ameri, Yumi J Hiramine, Zachary A Bogorad, Zhong Li, PhD, Zhongren Wu

Don H Bark, PhD's Documents

Publish Date Document Type Title
April, 2016 EIR Genentech, Inc. - EIR, 2016-04-15
July, 2015 FDA 483 Response Jubilant HollisterStier LLC - Form 483R, 2015-08-26
May, 2001 FDA 483 Response Wasserburger Arzneimittelwerk GmbH - Form 483R, 2001-05-22
April, 2008 EIR Pharmpur GmbH - EIR, 2008-06-05
May, 2001 EIR Wasserburger Arzneimittelwerk GmbH - EIR, 2001-09-05
February, 2016 FDA 483 Edmond Pharma S.r.l - Form 483, 2016-02-05
January, 2016 FDA 483 A. Nelson & Co. Ltd. - Form 483, 2016-01-29
February, 2004 EIR Jubilant HollisterStier LLC - EIR, 2004-02-25
February, 2004 FDA 483 Response Jubilant HollisterStier LLC - Form 483R, 2004-03-04
February, 2004 FDA 483 Jubilant HollisterStier LLC - Form 483, 2004-02-25
July, 2015 FDA 483 Jubilant HollisterStier LLC - Form 483, 2015-07-31
March, 2001 EIR Piramal Healthcare (Canada) Limited - EIR, 2001-06-04
March, 2002 FDA 483 Response Actavis Italy Spa A Socio Unico - Form 483R, 2002-04-02
May, 2017 FDA 483 Cilag AG - Form 483, 2017-05-19
March, 2002 FDA 483 Pharmacia & UpJohn - Form 483, 2002-03-19
March, 2002 EIR Actavis Italy Spa A Socio Unico - EIR, 2002-05-03
September, 2011 FDA 483 Charles River Laboratories Germany GmbH - Form 483, 2011-09-23
July, 2015 EIR Jubilant HollisterStier LLC - EIR, 2015-07-31
March, 2001 FDA 483 Piramal Healthcare (Canada) Limited - Form 483, 2001-03-15
March, 2010 FDA 483 Sandoz Industrial Products S.A - Form 483, 2010-03-12
May, 2017 FDA 483 Novartis Pharma Stein AG - Form 483, 2017-05-09
March, 2002 FDA 483 Santen Oy - Form 483, 2002-03-07

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more